HLHanqing Lin

Hanqing Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanqing Lin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Aodi Fan

    State Key Laboratory of Component‐Based Chinese Medicine & Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education Tianjin University of Traditional Chinese Medicine Tianjin China

    1 shared publication
  • Chuanrui Ma

    National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, 300193 Tianjin, China

    1 shared publication
  • Guanwei Fan

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China

    1 shared publication
  • Ke Yang

    State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education, Tianjin University of Traditional Chinese Medicine, 301617 Tianjin, China

    1 shared publication
  • Lan Li

    State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education, Tianjin University of Traditional Chinese Medicine, 301617 Tianjin, China

    1 shared publication
  • Xiangyu Zhu

    State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education, Tianjin University of Traditional Chinese Medicine, 301617 Tianjin, China

    1 shared publication

Latest Publications

  • Open Access

    Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease

    by Hanqing Lin, Xiangyu Zhu, Yuting Sun, Yakun Yang, Aodi Fan, Ke Yang, Zixuan Gao, Chuanrui Ma, Guanwei Fan, Lan Li

    Cardiovascular diseases (CVDs) are the primary cause of mortality globally. The Global Burden of Disease Study indicates that CVDs account for one-third of all global deaths, with a notable 18.17% increase in their incidence over the last decade. Despite the widespread use and proven effectiveness of therapies like antiplatelet agents, lipid-lowering drugs, anticoagulants, and percutaneous coronary intervention (PCI) in managing risk factors, the long-term prognosis of patients remains suboptimal. The prevailing academic viewpoint asserts that chronic inflammation and dysregulated apoptosis lead to the accumulation of apoptotic cells or fragments, triggering inflammatory injury and oxidative stress. Efferocytosis, encompassing the recognition, engulfment, and degradation of apoptotic cells by phagocytes, is essential for preserving tissue homeostasis and limiting excessive inflammation in this context. Macrophages, being professional phagocytes, demonstrate the highest efficiency and precision in clearing apoptotic cells. Hence, this review will center on macrophage-mediated efferocytosis, systematically investigating its roles and mechanisms in the pathogenesis and progression of CVDs.